Cart
sales@molnova.com
Perillen
CAS No. 539-52-6
Perillen( —— )
Catalog No. M18765 CAS No. 539-52-6
Perillen is an actiive constituent in the drug which promotes enterocinesia. Perillen demonstrates strong resistance activity against staphylococcus aureus and E.coli.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 156 | In Stock |
|
| 10MG | 231 | In Stock |
|
| 25MG | 389 | In Stock |
|
| 50MG | 574 | In Stock |
|
| 100MG | 801 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePerillen
-
NoteResearch use only, not for human use.
-
Brief DescriptionPerillen is an actiive constituent in the drug which promotes enterocinesia. Perillen demonstrates strong resistance activity against staphylococcus aureus and E.coli.
-
DescriptionPerillen is an actiive constituent in the drug which promotes enterocinesia. Perillen demonstrates strong resistance activity against staphylococcus aureus and E.coli.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number539-52-6
-
Formula Weight150.22
-
Molecular FormulaC10H14O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(=CCCC1=COC=C1)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Azido-PEG3-azide
Azido-PEG3-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
-
dY-V-G
H-D-Tyr-Val-Gly-OH is a catalyst of the synthesis of phenylhydrazones.
-
Metastin (human)
Potent endogenous ligand of the kisspeptin receptor (KISS1, GPR54). Binds with high affinity to rat and human KISS1 receptors with Ki values of 1.80 and 1.45 nM respectively. Inhibits chemotaxis, invasion and metastasis of human melanomas and breast carcinomas. Stimulates gonadotropin secretion following i.c.v. administration.
